Altair Therapeutics

company

About

Altair Therapeutics was a biopharmaceutical company that focused on developing therapeutics to treat human respiratory diseases.

  • 1 - 10

Details

Last Funding Type
Series B
Last Funding Money Raised
$17M
Industries
Biopharma,Biotechnology,Therapeutics
Founded date
Jan 1, 2007
Number Of Employee
1 - 10
Operating Status
Close

Altair Therapeutics is a biopharmaceutical company focused on developing therapeutics to treat human respiratory diseases.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$17M
Altair Therapeutics has raised a total of $17M in funding over 2 rounds. Their latest funding was raised on Feb 2, 2010 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 2, 2010 Series B $17M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Altair Therapeutics is funded by 1 investors. AgeChem Venture Fund are the most recent investors.
Investor Name Lead Investor Funding Round
AgeChem Venture Fund Series B